As per Market Research Future Analysis, the Bunion (Hallux Valgus) Treatment Market is projected to grow from 0.03 USD Billion in 2025 to 0.05 USD Billion by 2034, with a CAGR of approximately 6.80% during the forecast period. The increasing prevalence of bunions, particularly among older adults and women, along with the rising demand for minimally invasive surgical options, are key drivers of market growth. The market is also supported by the availability of various treatment methods, including surgical and non-surgical options, and the FDA's approval of new products.
The Bunion (Hallux Valgus) Treatment Market is witnessing significant growth due to various factors.
Key companies include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Smith & Nephew plc, and Wright Medical Technology, Inc.
Source Secondary Research, Primary Research, Market Research Future Database and Analyst Review
The rising number of bunion people drives market CAGR for bunion (hallux valgus) treatment. One in three Americans has bunion or hallux valgus, a prevalent foot ailment in adults. The condition is most frequently brought on narrow shoes for an extended period, by wearing uncomfortable, foot injuries, and genetic foot issues.
According to a study by NCBI,63% and 74% of the participants wore shoes that were either too short or too wide, which increased their risk of developing foot issues such as bunions, calluses, and deformities. This condition is more common in older adults, especially women, because their connective tissues are weaker, and they wear tight, heeled shoes more often. Growing arthritis prevalence is predicted to affect market expansion throughout the forecast period positively.
Inflammatory disease, such as rheumatoid arthritis, increases the risk of bunions. By a Vittori essay, 90% of rheumatoid arthritis patients ly experience foot issues. In rheumatoid arthritis, the body mistakenly attacks the linings of the big toes, increasing the risk of developing a bunion. Swelling and issues with joint movement are additional symptoms of both disorders that are expected to contribute to the market's growth.
The availability of a wide range of surgical and non-surgical techniques to control the issue, such as PROstep MIS, a non-invasive process. Orthopedic implants, bunion pads and tapings, painkillers, injections, surgery, and physical therapy treat bunions. The market is predicted to rise as more operations are used to treat the illness; for example, according to a San Mateo Podiatry Group article, about 150,000 surgeries are performed annually in the United States.
Additionally, the FDA's continued approval of new products is anticipated to fuel market expansion. The prevalence of working women and changing lifestyles have increased the chance of developing a bunion (hallux valgus), which has increased the demand for bunion treatment. Every year, around 150,000 bunion surgeries are carried out in the U.S. This is anticipated to significantly stimulate the bunion correction system industry. Additionally, the industry is further boosted by the rising approvals for various corrective systems. The FDA approved using the Lapiplasty 3D Bunion Correction System for pediatric patients in May 2019. Thus, driving the Bunion (Hallux Valgus) Treatment market revenue.
Based on the diagnosis, the Bunion (Hallux Valgus) Treatment market segmentation includes medical history, x-rays, and radiography. The x-rays segment dominated the market, accounting for 35% of market revenue. Bunion repair devices are used more frequently and in more surgical procedures as patients become more aware of them. Additionally, conditions including pregnancy, diabetes, or even rheumatoid arthritis can result in bunions. They are typically triggered by wearing ill-fitting footwear or excessively high heels. Regardless of the cause of your bunions, a variety of therapies can help you feel great in your shoes once more. Bunions require cautious treatment when it comes to foot care.
Based on treatment, the Bunion (Hallux Valgus) Treatment market segmentation includes self-care, medications, devices, and surgery. The surgery segment dominated the market, accounting for 35% of market revenue. The most frequent surgical treatment for bunions is a bunionectomy. The bony hump must be removed, and the damaged bones and soft tissues must be realigned. Osteotomy To repair the abnormality, the big toe's bones are sliced and repositioned during this treatment.Arthrodesis Joint fusion may be performed to give long-term pain relief and stability in extreme cases where other therapies have failed.
Based on end users, the Bunion (Hallux Valgus), Treatment market segmentation includes healthcare service providers and podiatrists. The healthcare service providers segment generated the most income (70.4%). Positive market growth was influenced by the increasing number of patients having corrective procedures at the hospitals. In addition, the accessibility of minimally invasive surgical alternatives for the condition is anticipated to accelerate segment expansion over the projected year. To relieve the discomfort and swelling in the foot, surgical techniques often involve removing the swollen tissue and realigning and aligning the bones in the foot.
Figure 1 Bunion (Hallux Valgus) Treatment Market, by End User, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Bunion (Hallux Valgus) Treatment market will dominate this market; the market in the area includes the higher prevalence of the ailment there and the accessibility of treatment centers for corrective operations.
Hence, the major countries studied in the market report are The US, Canada, German, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 BUNION (HALLUX VALGUS) TREATMENT MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Due to the expanding use of technology, the European Bunion (Hallux Valgus) Treatment market holds the second-largest market share. The market for Bunion (Hallux Valgus) Treatment in Germany had the biggest market share, and the market in the U.K. had the quickest growth rate in Europe.
The Bunion (Hallux Valgus) Treatment Market in Asia-Pacific is anticipated to see the quickest CAGR between 2023 and 2032. The rise of the regional market is predicted to be positively impacted by growing senior populations in countries like China, Japan, and India, as well as an increase in healthcare tourism. In addition, the Indian Bunion (Hallux Valgus) Treatment market had the quickest growth rate in the Asia-Pacific region. In contrast, China's Bunion (Hallux Valgus) Treatment market had the greatest market share.
Leading industry companies are making significant R&D investments to diversify their product offerings, which will expand the Bunion (Hallux Valgus) Treatment market. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants also engage in several strategic actions to increase their worldwide presence. The Bunion (Hallux Valgus) Treatment industry must produce inexpensive products to expand and survive in a more competitive and tough market climate.
Local manufacturing to minimize operating costs is one of the key business tactics manufacturers use in the Bunion (Hallux Valgus) Treatment industry to support clients and increase the market sector. In recent years, the Bunion (Hallux Valgus) Treatment industry has offered some of the most significant advantages. Major players in the Bunion (Hallux Valgus) Treatment market, including Stryker, are attempting to increase market demand by investing in research and development operations.
Stryker, one of the top medical equipment manufacturers worldwide, is committed to improving healthcare with its clients. The business provides cutting-edge orthopedic, medical, and surgical, as well as neurotechnology and spine products and services that enhance patient and hospital results. In September 2021, The medical equipment business Gauss Surgical, which created the artificial intelligence-enabled Triton platform, was acquired by Stryker. This technology was created to track blood loss in real time during surgery. After this acquisition, Stryer sought to use this technology to enhance patient and carer safety and outcomes.
The research, production, and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT, and advanced wound treatment are the main business activities of Smith & Nephew Plc (Smith & Nephew). The business provides robotics-assisted technologies, knee and hip implants to replace sick, worn, or damaged joints, trauma-related items to stabilise fractures, and deformity repair operations. Additionally, it provides items for treating wounds as well as tools and materials for removing and repairing soft tissue.
| Attribute/Metric | Details |
| Market Size 2024 | 0.02 (USD Billion) |
| Market Size 2025 | 0.03 (USD Billion) |
| Market Size 2034 | 0.05 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.80 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Distribution Channel, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.), De Puy Synthes (U.S.), Biomet, Inc. (U.S.), BioPro, Inc. (U.S.), Orthofix Holdings Inc. (U.S.), OrthoHelix Surgical Designs, Inc. (U.S.), Mondeal Medical Systems GmbH (Germany) |
| Key Market Opportunities | Mergers and acquisitions are also expected to contribute to the market growth |
| Key Market Dynamics | High prevalence of bunion (hallux valgus) in the overall population |
Bunion Treatment Market Highlights:
Frequently Asked Questions (FAQ):
The Bunion (Hallux Valgus) Treatment market size was valued at USD 0.021 Billion in 2022.
The market is projected to grow at a CAGR of 6.80% during the forecast period, 2025-2034
North America had the largest share in the market
The key players in the market are Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.).
The surgery dominated the market in 2022.
The hospitals service providers had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
